» Authors » Jorge Saucedo

Jorge Saucedo

Explore the profile of Jorge Saucedo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 587
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Saucedo J, Lozano Feria F, Ramirez A
Cureus . 2025 Feb; 17(1):e77372. PMID: 39949441
Neurotrophic keratitis is a rare corneal degenerative disorder characterized by decreased sensory innervation, leading to epithelial defects and impaired wound healing. This report presents a case of a 60-year-old female...
2.
Giacoppo D, Saucedo J, Scheller B
J Soc Cardiovasc Angiogr Interv . 2024 Aug; 2(3):100625. PMID: 39130710
Drug-coated balloons are approved outside the United States, not only for the treatment of peripheral arteries but also for coronary arteries. This review describes the technological basics, the scenarios of...
3.
Zhang D, Gao H, Song X, Raposeiras-Roubin S, Abu-Assi E, Paulo Simao Henriques J, et al.
Diabetes Res Clin Pract . 2023 Jul; 203:110833. PMID: 37478977
Aims: We aimed to explored the association between the use of optimal medical therapy (OMT) in patients with myocardial infarction (AMI) and diabetes mellitus (DM) and clinical outcomes. Methods: Bleeding...
4.
Zhang Z, Yan Y, Li S, Raposeiras-Roubin S, Abu-Assi E, Henriques J, et al.
J Geriatr Cardiol . 2023 Jan; 19(12):981-989. PMID: 36632206
Background: Haemoglobin drop is common in acute coronary syndrome (ACS) patients and correlates with poor prognosis. However, the association between mild haemoglobin drop and adverse clinical outcome remains insufficiently investigated....
5.
Zhang D, Song X, Raposeiras-Roubin S, Abu-Assi E, Paulo Simao Henriques J, DAscenzo F, et al.
Ther Adv Chronic Dis . 2021 Nov; 12:20406223211046999. PMID: 34729148
Background: Treatment of acute myocardial infarction (AMI) patients with prior stroke is a common clinical dilemma. Currently, the application of optimal medical therapy (OMT) and its impact on clinical outcomes...
6.
Sosa Liprandi A, Sosa Liprandi M, Zaidel E, Aisenberg G, Baranchuk A, Barbosa E, et al.
Glob Heart . 2021 Aug; 16(1):55. PMID: 34381676
Background: Cardiovascular mortality is decreasing but remains the leading cause of death world-wide. Respiratory infections such as influenza significantly contribute to morbidity and mortality in patients with cardiovascular disease. Despite...
7.
Guerrero M, Pursnani A, Narang A, Salinger M, Wang D, Eleid M, et al.
JACC Cardiovasc Interv . 2021 Apr; 14(8):859-872. PMID: 33888231
Objectives: The aim of this study was to assess 1-year clinical outcomes among high-risk patients with failed surgical mitral bioprostheses who underwent transseptal mitral valve-in-valve (MViV) with the SAPIEN 3...
8.
Brown S, Patel S, Rayan D, Zaharova S, Lin M, Nafee T, et al.
Cardiooncology . 2021 Jan; 7(1):2. PMID: 33441188
Background: As cardiovascular disease is a leading cause of death in cancer survivors, the new subspecialty of Cardio-Oncology has emerged to address prevention, monitoring, and management of cardiovascular toxicities to...
9.
Saeed H, Ovalle O, Bokhary U, Jermihov A, Lepkowska K, Bauer V, et al.
Clin Appl Thromb Hemost . 2020 Oct; 26:1076029620952550. PMID: 33079570
Introduction: NVAF is estimated to affect between 6.4 and 7.4 million Americans in 2018, and increases the risk of stroke 5-fold. To mitigate this risk, guidelines recommend anticoagulating AF patients...
10.
Moussa I, Mohananey D, Saucedo J, Stone G, Yeh R, Kennedy K, et al.
J Am Coll Cardiol . 2020 Sep; 76(13):1521-1531. PMID: 32972528
Background: There is a paucity of data on the burden of in-stent restenosis (ISR) in the United States as well as on its presentation and appropriate treatment strategies. Objectives: This...